Filter Results :

Your search for inhibitors returned 480 reports

Sort by


Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Organic Corrosion Inhibitors Market 2017 Forecast to 2022

18 Jul 2017  |  Published by:  Global Info Research
Corrosion processes are responsible for numerous losses mainly in the industrial scope. It isclear that the best way to combat it is prevention. Among the various methods to avoid or prevent destruction or degradation of metal surface, the corrosion inhibitor is one of the best know methods of corro...

$ 4,880.00

Read More

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2017

03 Jul 2017  |  Published by:  QYResearch
In this report, the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report is segmented into several key Regions, with productio...

$ 2,900.00

Read More

PD-1 and PD-L1 Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “PD-1 and PD-L1 Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed andpip...

$ 2,950.00

Read More

Janus Kinase (JAK) Inhibitors - Competitive Landscape, Technology and Pipeline Analysis, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “Janus Kinase (JAK) Inhibitors- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and...

$ 2,450.00

Read More

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this mechanism of action. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fi...

$ 1,250.00

Read More

United States Organic Corrosion Inhibitors Market by Manufacturers, States, Type and Application, Forecast to 2022

26 Jun 2017  |  Published by:  Global Info Research
Corrosion processes are responsible for numerous losses mainly in the industrial scope. It isclear that the best way to combat it is prevention. Among the various methods to avoid or prevent destruction or degradation of metal surface, the corrosion inhibitor is one of the best know methods of corro...

$ 4,480.00

Read More

Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

13 Jun 2017  |  Published by:  GBI Research
SummaryIn 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis. These are generally incurable once they progress to the stage where they are unresectable. Chemotherapy compounds are a mainstay treatment for cancers of all types, at various disease stages...

$ 4,995.00

Read More

Bromodomain and Extra-terminal Domain Protein (BET) Inhibitors - Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “Bromodomain and Extra-terminal Domain Protein (BET) Inhibitors-Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipelin...

$ 1,125.00

Read More

Proprotein Convertase Subtilisin Kexin 9 (PCSK-9) Inhibitors -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “Proprotein Convertase Subtilisin Kexin 9 (PCSK-9) Inhibitors-Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline ...

$ 1,250.00

Read More

Phosphoinositide 3-Kinase Inhibitor (PI3k) Inhibitors - Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “Phosphoinositide 3-Kinase Inhibitor (PI3k) Inhibitors-Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs t...

$ 1,750.00

Read More

Tankyrase PARP5A (poly(ADP-ribosyl)transferase 5a) Inhibitors -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Tankyrase PARP5A (poly(ADP-ribosyl)transferase 5a) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Tankyrase PARP5A (poly(ADP-ribosyl)transferase 5a) Inhibitors. The DelveInsight’s Report covers ...

$ 1,250.00

Read More

RET (Ret Proto-Oncogene) protein inhibitors -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“RET (Ret Proto-Oncogene) protein inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the RET (Ret Proto-Oncogene) protein inhibitors. The DelveInsight’s Report covers the product profiles in various stag...

$ 1,250.00

Read More

Enhancer of zeste homolog 2 (EZH2) inhibitors -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Enhancer of zeste homolog 2 (EZH2) inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Enhancer of zeste homolog 2 (EZH2) inhibitors. The DelveInsight’s Report covers the product profiles in various ...

$ 1,250.00

Read More

Isocitrate Dehydrogenase (IDH1) inhibitors -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Isocitrate Dehydrogenase (IDH1) inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Isocitrate Dehydrogenase (IDH1) inhibitors. The DelveInsight’s Report covers the product profiles in various stages...

$ 1,250.00

Read More

Ubiquitin conjugating enzyme inhibitors -Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s,“Ubiquitin conjugating enzyme inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Ubiquitin conjugating enzyme inhibitors. The DelveInsight’s Report covers the product profiles in various stages of de...

$ 1,250.00

Read More
Total 480 records.